IL83953A - Vaccine comprising a bacterial flagella protein conjugated to an antigen and method of preparation - Google Patents

Vaccine comprising a bacterial flagella protein conjugated to an antigen and method of preparation

Info

Publication number
IL83953A
IL83953A IL8783953A IL8395387A IL83953A IL 83953 A IL83953 A IL 83953A IL 8783953 A IL8783953 A IL 8783953A IL 8395387 A IL8395387 A IL 8395387A IL 83953 A IL83953 A IL 83953A
Authority
IL
Israel
Prior art keywords
vaccine
antigen
preparation
protein conjugated
bacterial flagella
Prior art date
Application number
IL8783953A
Other languages
English (en)
Other versions
IL83953A0 (en
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of IL83953A0 publication Critical patent/IL83953A0/xx
Publication of IL83953A publication Critical patent/IL83953A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL8783953A 1986-09-22 1987-09-21 Vaccine comprising a bacterial flagella protein conjugated to an antigen and method of preparation IL83953A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16

Publications (2)

Publication Number Publication Date
IL83953A0 IL83953A0 (en) 1988-02-29
IL83953A true IL83953A (en) 1992-05-25

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8783953A IL83953A (en) 1986-09-22 1987-09-21 Vaccine comprising a bacterial flagella protein conjugated to an antigen and method of preparation

Country Status (17)

Country Link
EP (1) EP0283505B1 (de)
JP (1) JPH01501064A (de)
KR (1) KR920002165B1 (de)
CN (1) CN1030019A (de)
AP (1) AP8700068A0 (de)
AT (1) ATE108067T1 (de)
BR (1) BR8707471A (de)
CA (1) CA1322721C (de)
DE (1) DE3750176T2 (de)
DK (1) DK272688A (de)
ES (1) ES2007720A6 (de)
FI (1) FI882397A0 (de)
GR (1) GR871460B (de)
IL (1) IL83953A (de)
NZ (2) NZ236829A (de)
PT (1) PT85760B (de)
WO (1) WO1988001873A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226811A (en) * 1987-11-03 1991-06-25 Syntex Inc Adjuvant emulsion comprising a glycopeptide and non-toxic tetra-polyol or pop-poe block copolymer wherein oily particle size is less than 800am
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
US7138252B2 (en) 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
CA2487849A1 (en) 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
EP2338510A1 (de) 2002-07-19 2011-06-29 Novartis Pharma AG Impfstoffzusammensetzungen, die Amyloid-beta1-6 Antigen-Arrays enthalten
EP1536832A2 (de) * 2002-09-03 2005-06-08 Fondation Eurovacc Flagellin peptide als adjuvantien für impfstoffe
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
US8728492B2 (en) * 2008-01-18 2014-05-20 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
AU2009236585B2 (en) 2008-04-18 2013-03-07 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
WO2011028875A1 (en) * 2009-09-03 2011-03-10 Wake Forest University Health Sciences Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
WO1979000160A1 (en) * 1977-09-28 1979-04-05 Nat Res Dev Improvements in or relating to immunological preparations
EP0031812B1 (de) * 1979-03-27 1983-06-15 National Research Development Corporation Verbesserungen an immunologischen zusammensetzungen
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
AU629103B2 (en) 1992-09-24
EP0283505B1 (de) 1994-07-06
KR880701560A (ko) 1988-11-03
AP8700068A0 (en) 1989-03-21
NZ221868A (en) 1991-03-26
NZ236829A (en) 1993-07-27
PT85760B (pt) 1990-08-31
EP0283505A4 (de) 1989-11-07
IL83953A0 (en) 1988-02-29
FI882397A7 (fi) 1988-05-20
CA1322721C (en) 1993-10-05
KR920002165B1 (ko) 1992-03-19
AU7113191A (en) 1991-07-11
WO1988001873A1 (en) 1988-03-24
DE3750176T2 (de) 1994-10-13
CN1030019A (zh) 1989-01-04
AU8023287A (en) 1988-04-07
EP0283505A1 (de) 1988-09-28
GR871460B (en) 1988-03-21
FI882397L (fi) 1988-05-20
FI882397A0 (fi) 1988-05-20
ATE108067T1 (de) 1994-07-15
AU613588B2 (en) 1991-08-08
DE3750176D1 (de) 1994-08-11
PT85760A (en) 1987-10-01
DK272688D0 (da) 1988-05-18
DK272688A (da) 1988-07-12
ES2007720A6 (es) 1989-07-01
JPH01501064A (ja) 1989-04-13
BR8707471A (pt) 1988-09-13

Similar Documents

Publication Publication Date Title
IL83953A (en) Vaccine comprising a bacterial flagella protein conjugated to an antigen and method of preparation
PT77515A (en) Immunogenic protein or peptide complex method of producing said complex and use thereof as an immune stimulant and as a vaccine
GB2217600B (en) Vaccine preparation comprising a vaccine and a toxin
EP0314315A3 (en) Preparation of hydroxy terminated polysiloxanes
AU6698786A (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
AU1270188A (en) Preparation and method for permanent shaping of hair
EP0233615A3 (en) Aqueous preparation and method of preparation thereof
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
NZ211715A (en) Peptide containing an antigenic site of gonococcal pilin/protein
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
AU629103C (en) Vaccine and method of preparation
IE872543L (en) Vaccine and method of preparation
ZA877087B (en) Vaccine and method of preparation
EP0255755A3 (de) Impfstoffzubereitung
AU558071B2 (en) Live vaccine for bovine babesiosis and method of preparation
CS370187A1 (en) Polyvalent inactivated adsorbate vaccine against foals' infective bronchopneumonie and method of its preparation
RO101947B1 (en) Marek's disease vaccine and preparation method
IE861786L (en) Immunogenic peptide antigen corresponding to plasmodium¹vivaz circumsporozoite protein
BG42262A1 (en) Conjugate of beta- amanitine and concanavaline a and method for its preparation
GB2223757B (en) Excretory/secretory antigens of tapeworm (cysticerus cellulosae) for use in immunodiagnosis and vaccine preparation
CS323288A1 (en) Acrylonitrile-butylacrylate latex and method of its preparation
CS25886A1 (en) 2-substituted-5-arylfurans and method of their preparation
PL267231A1 (en) Method of obtaining enzootic cattle leukaemia virus antigen
CS945586A1 (en) Aqua-l-asparagane-magnesium complex and method of its preparation
PL276132A1 (en) Method of obtaining pigmentous preparations

Legal Events

Date Code Title Description
RH Patent void